|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.86 USD | +0.12% |
|
0.00% | +80.15% |
| Market Cap | 8.89B 7.72B 7.2B 6.62B 12.51B 846B 12.65B 84.9B 33.19B 423B 33.4B 32.67B 1,401B | P/E 2026 * |
-17.8x | P/E 2027 * | -20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 7.86B 6.82B 6.36B 5.85B 11.05B 748B 11.18B 75.02B 29.33B 374B 29.52B 28.87B 1,238B | EV / Sales 2026 * |
134x | EV / Sales 2027 * | 46.6x |
| Free-Float |
97.97% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Crinetics Pharmaceuticals, Inc.
| 1 day | +0.12% | ||
| Current month | +0.41% | ||
| 1 month | +98.58% | ||
| 3 months | +103.30% | ||
| 6 months | +76.81% | ||
| Current year | +80.15% |
| 1 week | 83.47 |  | 84.02 |
| 1 month | 41.39 | | 84.02 |
| Current year | 32.3 | | 84.02 |
| 1 year | 25.83 | | 84.02 |
| 3 years | 15.76 | | 84.02 |
| 5 years | 15.23 | | 84.02 |
| 10 years | 10.63 | | 84.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
R. Struthers
CEO | Chief Executive Officer | 64 | 2008-11-30 |
Stephen Betz
CTO | Chief Tech/Sci/R&D Officer | 60 | 2021-09-30 |
Tobin Schilke
DFI | Director of Finance/CFO | 51 | 2025-02-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Wendell Wierenga
CHM | Chairman | 78 | 2015-09-30 |
R. Struthers
BRD | Director/Board Member | 64 | 2008-10-31 |
Matthew Fust
BRD | Director/Board Member | 61 | 2018-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/2/26 | Sell | Director | -3,000 | 0.0028% | ||
| 3/12/26 | Sell | Director | 5,000 | 0.0048% | ||
| 2/23/26 | Free | Chief Financial Officer | 82,000 | 0.0871% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.12% | 0.00% | +197.17% | +348.45% | 8.83B | |
| +10.00% | +14.90% | +53.89% | +87.07% | 56.7B | |
| +0.80% | -5.70% | +23.89% | +62.65% | 51.97B | |
| -0.98% | -1.19% | -16.98% | -14.21% | 23.33B | |
| +0.30% | -5.17% | -11.23% | +349.07% | 21.34B | |
| +1.73% | -1.57% | +32.81% | -25.80% | 17.44B | |
| +4.29% | +8.97% | +200.03% | +341.85% | 14.77B | |
| +1.71% | -0.90% | +52.13% | +176.27% | 13.84B | |
| +4.16% | +4.44% | +444.12% | +183.06% | 12.12B | |
| +5.30% | -5.80% | +62.62% | +160.98% | 11.14B | |
| Average | +2.74% | -0.01% | +103.85% | +166.94% | 23.15B | |
| Weighted average by Cap. | +3.54% | +1.13% | +67.96% | +127.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 58.81M 51.07M 47.61M 43.74M 82.72M 5.59B 83.63M 561M 219M 2.8B 221M 216M 9.27B | 172M 150M 139M 128M 242M 16.38B 245M 1.64B 642M 8.19B 647M 632M 27.13B |
| Net income | -516M -448M -418M -384M -726M -49.13B -734M -4.93B -1.93B -24.56B -1.94B -1.9B -81.37B | -473M -410M -383M -351M -665M -44.95B -672M -4.51B -1.76B -22.47B -1.77B -1.74B -74.46B |
| Net Debt | -1.04B -899M -838M -770M -1.46B -98.46B -1.47B -9.88B -3.86B -49.22B -3.89B -3.8B -163B | -865M -751M -700M -643M -1.22B -82.3B -1.23B -8.26B -3.23B -41.14B -3.25B -3.18B -136B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | US$83.86 | +0.12% | 2,725,900 |
| 26-08-03 | US$83.76 | +0.29% | 1,745,072 |
| 26-07-31 | US$83.52 | -0.13% | 1,863,939 |
| 26-07-30 | US$83.63 | -0.30% | 2,109,649 |
| 26-07-29 | US$83.88 | +0.02% | 1,621,555 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
